Skip to main content

. 1993 Jun;56(6):722–723. doi: 10.1136/jnnp.56.6.722

HLA class II susceptibility and resistance genes in patients with multiple sclerosis from northern Spain, by DNA-RFLP genotyping.

D F Uría, V Gutierrez, B B Menes, J M Arribas, C Lopez-Larrea

PMCID: PMC489634 PMID: 8099604

722

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bidwell J. DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens. Immunol Today. 1988 Jan;9(1):18–23. doi: 10.1016/0167-5699(88)91351-5. [DOI] [PubMed] [Google Scholar]
Haegert D. G., Michaud M., Schwab C., Francis G. S. Multiple sclerosis and HLA class II susceptibility and resistance genes. J Neurosci Res. 1990 May;26(1):66–73. doi: 10.1002/jnr.490260108. [DOI] [PubMed] [Google Scholar]
Olerup O., Hillert J., Fredrikson S., Olsson T., Kam-Hansen S., Möller E., Carlsson B., Wallin J. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7113–7117. doi: 10.1073/pnas.86.18.7113. [DOI] [PMC free article] [PubMed] [Google Scholar]
Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
Victoria-Gutierrez M., Martinez-Naves E., Coto E., Dominguez O., Uría F., Urra J. M., López-Larrea C. DNA analysis of HLA-DR4B1 subtypes in multiple sclerosis by specific oligonucleotide probes. J Neuroimmunol. 1991 Jun;32(3):279–283. doi: 10.1016/0165-5728(91)90198-g. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES